Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 129 The United Laboratories International Holdings Limited Annual Report 2022 34. CAPITAL COMMITMENTS 2022 2021 RMB’000 RMB’000 Capital expenditure in respect of the acquisition of property, plant and equipment contracted for but not provided in the consolidated financial statements 355,691 293,642 35. DERIVATIVE FINANCIAL INSTRUMENTS 2022 2021 RMB’000 RMB’000 Foreign currency forward contracts – asset 1,841 – Foreign currency forward contract – liability (10,087) – Cross currency interest rate swap – liability – (5,812) (8,246) (5,812) The Group’s derivative financial instruments represent foreign currency forward contracts and a cross currency interest rate swap contract for hedging a portion of its foreign exchange risk related to its bank borrowings denominated in foreign currencies.